CDMO News
Porton Advanced Signs MOU with EVA Pharma to Expand CAR-T Manufacturing in MEA
Porton Advanced Solutions and EVA Pharma have signed a Memorandum of Understanding (MOU) to collaborate on cell and gene therapy development, focusing on the manufacturing of CAR T-cell therapies in the Middle East and Africa (MEA). The agreement will prioritise lentiviral
27 June 2025
Stay ahead of trends and best practices
